The Contract Research Organizations (CROs) are of utmost importance in the worldwide pharmaceuticals, the biotech industry and medical devices in the provision of specialized research and development services. The CRO market has undergone significant growth, propelled by the increasing outsourcing trend, cost pressures, and the need for faster drug development. India is on its way to becoming a major base on the low operational costs and a workforce of qualified scientists. In-house research capabilities at CROs have changed rapidly, incorporating artificial intelligence, big data analytics, and decentralized clinical trials in a manner to improve efficiency. The introduction of new technologies and the implementation of advanced molecular studies such as RNAseq technology or Single-cell high-dimensional analysis are some examples of CROs' involvement in the innovation in the field of drug discovery and development.

The CRO sector enjoys a fast track and is greatly inspired by the growth in R&D investments, a mounting number of clinical trials, and regulatory complexities that have been the reason for more outsourcing of the conduct of the research. In the case of small and medium biotech companies, in particular, they need CROs to help to navigate the regulatory landscape and duly conduct global trials. On the contrary to this prevailing trend, there are dark sides to the industry like the regulatory hurdles, the data...